The study proposes to rigorously evaluate a proactive, culturally responsive care navigator intervention targeting younger-onset Latinx individuals with a new T2D diagnosis (AURORA \[Active Outreach to Younger Latinx\]) within Kaiser Permanente Northern California (KPNC).
The study has three primary objectives: 1) learn what is required to create and sustain a care navigator workforce and document our experience hiring a care navigator for the study, 2) implement and evaluate the AURORA strategy within KPNC, and 3) refine and adapt the AURORA strategy for future Kaiser Permanente (KP) wide dissemination. The AURORA strategy centers on a care navigator who will proactively conduct three telemedicine visits tailored to Latinx adults with early onset type 2 diabetes (T2D, defined as age \<45 years). The AURORA strategy will conducted with the following five goals: 1) assessment of familiarity and use of T2D care within KP, 2) assessment of individual's self-management support needs, 3) motivational interviewing to support behavior change, 4) pragmatic skills training, including use of crucial technologies to support self-management, and 5) matching member's needs with existing KPNC T2D resources.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
204
Participants will be invited to partake in three telemedicine visits with the care navigator during the months following diagnosis. The visits center around proactive and tailored T2D self-management support.
Kaiser Permanente Northern California
Oakland, California, United States
RECRUITINGDifferences between study arms in HbA1c change 6-months following enrollment
Change in HbA1c will be assessed using HbA1c values obtained through routine care, with the most recent HbA1c preceding study enrollment and the HbA1c value closest to 6-months following enrollment used to assess HbA1c change.
Time frame: 6-months following enrollment
Healthcare contact
Differences in healthcare contact with members of the T2D diabetes care team, including care manager, PCPs, educators.
Time frame: 6-months following enrollment
Completion of recommended HbA1c monitoring
Completing HbA1c labs
Time frame: 6-months following enrollment
T2D-related medication initiation
Initiation of T2D-related medication
Time frame: 6-months following enrollment
T2D-related medication adherence
Adherence to T2D-related medication
Time frame: 6-months following enrollment
Use of remote glucose monitoring to measure glucose levels
Use of a remote glucose monitoring to measure glucose levels
Time frame: 6-months following enrollment
Participant-reported measures: Confidence in Accessing Care
Assessed at 3-month survey
Time frame: 3-months following enrollment
Participant-reported measures: Diet and Exercise
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Assessed at 3-month survey
Time frame: 3-months following enrollment
Participant-reported measures: Self-efficacy for diabetes
Assessed at 3-month survey
Time frame: 3-months following enrollment
Participant-reported measures: Motivation and locus of control
Assessed at 3-month survey
Time frame: 3-months following enrollment
Participant-reported measures: Diabetes distress
Assessed at 3-month survey
Time frame: 3-months following enrollment
Participant-reported measures: Diabetes stigma
Assessed at 3-month survey
Time frame: 3-months following enrollment